India has joined the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub as a new member. This was announced by the Department of Biotechnology, Ministry of Science & Technology in New Delhi.
The Global AMR R&D Hub was launched in May 2018 and supports global priority setting and evidence-based decision-making on the allocation of resources for AMR R&D through the identification of gaps, overlaps and potential for cross-sectoral collaboration and leveraging in AMR R&D.
The hub is aimed at helping countries decide the allocation of resources for research and development (R&D) on antimicrobial resistance (AMR) by identifying gaps and overlaps. It will also promote coordination among governments in the fight against AMR.
The global partnership now includes 16 countries, the European Commission, two philanthropic foundations and four international organisations. With India as a member, the Hub now represents more than half the world’s population.
India is among countries with the highest bacterial disease burden in the world, and therefore AMR-Global is also looking for partnerships in India.
AMR-Global recently signed a letter of intent for a new partnership to leverage collective expertise of India and the Netherlands to impact antimicrobial resistance around the world. with C-CAMP (Centre for Cellular and Molecular Platforms) based in Bangalore.
Addressing AMR requires global action with active participation from all world regions and One Health sectors. Expanding the membership of the Hub with India, as well as the relation between AMR-Global and India all works towards ensuring that the needs of India are incorporated when considering AMR R&D activities and actions.